Sign in

CIK 0001604821

  • Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010894487
Phone
+1 650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$104,832,418
in 28 filings, $104.8M under 10b5-1 plans

Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-12-02 BOTHA ROELOF Director Sale −11,219 $170.54 $1.9M 1,224,787
2024-11-26 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −660 $163.25 $108K 85,340
2024-11-26 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −940 $164.24 $154K 84,400
2024-11-26 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −400 $165.55 $66K 84,000
2024-11-25 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −1,089 $167.89 $183K 86,911
2024-11-25 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −600 $168.91 $101K 86,311
2024-11-25 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −311 $169.94 $53K 86,000
2024-11-19 Marcus Gail Boxer Director Sale −7,582 $159.83 $1.2M 11,804
2024-11-19 Marcus Gail Boxer Director Sale −2,100 $160.52 $337K 9,704
2024-11-15 Baynes Roy D. Director Exercise or conversion 10b5-1 +22,000 $22.83 $502K 37,807
2024-11-15 Baynes Roy D. Director Exercise or conversion 10b5-1 +15,230 $24.42 $372K 53,037
2024-11-15 Baynes Roy D. Director Sale 10b5-1 −5,500 $144.26 $793K 47,537
2024-11-15 Baynes Roy D. Director Sale 10b5-1 −16,404 $145.21 $2.4M 31,133
2024-11-15 Baynes Roy D. Director Sale 10b5-1 −1,770 $146.26 $259K 29,363
2024-11-15 Baynes Roy D. Director Sale 10b5-1 −9,467 $147.31 $1.4M 19,896
2024-11-15 Baynes Roy D. Director Sale 10b5-1 −2,106 $148.74 $313K 17,790
2024-11-15 Baynes Roy D. Director Sale 10b5-1 −1,983 $149.98 $297K 15,807
2024-11-15 Baynes Roy D. Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −22,000 0
2024-11-15 Baynes Roy D. Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −15,230 0
2024-11-15 Chapman Steven Leonard CEO AND PRESIDENT Sale 10b5-1 −985 $144.44 $142K 188,777

Page 62 of 85 · 1,682 trades